Overview and Scope
Lab automation in drug discovery refers to the use of advanced technologies and robotics to streamline and optimize laboratory processes related to new drug development and research. It is used to significantly enhance the speed and success rate of drug discovery efforts by automating repetitive tasks and integrating advanced instruments and software.
Sizing and Forecast
The lab automation in drug discovery market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.47 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the increasing complexity of drug discovery, demand for efficiency and cost reduction, growing need for high-throughput screening, rising labor costs, and pressure to accelerate drug development timelines.
The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $7.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to expanding drug pipelines of pharmaceutical companies, rise in personalized medicine and precision therapeutics, increasing focus on rare diseases and orphan drugs, demand for remote and decentralized clinical trials, the emergence of microfluidics and lab-on-a-chip technologies. Major trends in the forecast period include proliferation of modular and customizable automation solutions, adoption of cloud-based platforms for data management and collaboration, growth of automation in emerging markets, rise of virtual drug discovery companies leveraging automation and digital technologies, development of standardized protocols and interoperable systems.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report
Segmentation & Regional Insights
The lab automation in drug discovery market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users
North America was the largest region in the lab automation in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=14410&type=smp
Major Driver Impacting Market Growth
The increasing demand for precision medicine is expected to propel the growth of lab automation in the drug discovery market going forward. Precision medicine, also known as personalized medicine, is an approach to medical treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Lab automation accelerates research, improves experimental repeatability, and improves the efficiency of precision medicine and drug discovery procedures, ultimately leading to the creation of more effective medicines and diagnostics suited to individual patients. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines will be on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Therefore, the increasing demand for precision medicine is driving the growth of lab automation in the drug discovery market.
Key Industry Players
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation
The lab automation in drug discovery market report table of contents includes:
1. Executive Summary
.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope The micro-flute paper refers to fluted corrugated sheets with one or two…
Overview and Scope IO-link refers to an open standard communication link for sensors and actuators…
Overview and Scope Ophthalmic drugs refer to a class of pharmaceutical drugs or medicines used…
Overview and Scope Inventory tags are labels or markings attached to items or containers and…
Overview and Scope An oncology-based in-vivo contract research organization (CRO) refers to a company hired…
Overview and Scope An intubation tube is a medical device used to establish and maintain…